Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
8434
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Disposal of treasury shares as restricted stock compensation
Who receives how much
8,434 common shares of the Company (5,246 shares for directors, 1,446 shares for the Company’s corporate officers, and 1,742 shares for directors and corporate officers of the Company’s domestic subsidiaries)
Directors of the Company, excluding outside directors5 / 5,246 shares
Corporate officers of the Company9 / 1,446 shares
Directors and corporate officers of the Company’s domestic subsidiaries13 / 1,742 shares
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
¥21,380 per share
Total issue value
¥180,318,920
Amount of funds to be raised
Total payment amount: ¥180,318,920; estimated net proceeds: Not disclosed
Total Stock-Based Compensation
Covered directors: total monetary compensation receivables of ¥112,159,480. Covered corporate officers and others: total monetary receivables of ¥68,159,440. The compensation framework separate from the existing monetary compensation framework is limited to ¥200 million per year (the amount recognized as an accounting expense).
発行済株式総数
The total number of issued shares will not increase because this is a disposal of treasury shares.
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Transfer restriction period
Covered directors: from 15 May 2026 to 15 May 2029. Covered corporate officers and others: from 15 May 2026 until the date on which they cease to hold any of the positions specified according to their respective status.
Conditions for lifting transfer restrictions
Covered directors must continuously hold the prescribed position from the date of the immediately preceding annual general meeting of shareholders as of 15 May 2026 through the date of the following annual general meeting of shareholders. Covered corporate officers and others must continuously hold the prescribed position during the service period corresponding to their respective status. If they lose the position due to death or another reason deemed justifiable by the Board of Directors, some or all of the restrictions will be lifted in proportion to the period of service. In the event of a reorganization or similar transaction, all restrictions will be lifted immediately before the business day preceding the effective date.
Reason for acquisition without consideration
Upon expiration of the restriction period or immediately after the loss of the prescribed position, the Company will automatically acquire without consideration any shares for which the restrictions have not been lifted.
Categories and Number of Persons Covered
5 directors of the Company, excluding outside directors, 5,246 shares; 9 corporate officers (executive officers) of the Company, 1,446 shares; and 13 directors and corporate officers (executive officers) of the Company's domestic subsidiaries, 1,742 shares
Intended allottee's holding policy
During the restriction period, the shares may not be transferred, pledged or otherwise disposed of. For the covered corporate officers and others, the policy is to promote long-term, stable share ownership.
Payment date
15 May 2026
Basis for determining the amount to be paid
The closing price of the Company’s common shares on the Tokyo Stock Exchange market on 16 April 2026 was ¥21,380. No discount or premium rate was stated.
| Item | Details |
|---|---|
| Type of issuance or disposal | Disposal of treasury shares as restricted stock compensation |
| Number of shares to be issued or disposed of | 8,434 common shares of the Company (5,246 shares for directors, 1,446 shares for the Company’s corporate officers, and 1,742 shares for directors and corporate officers of the Company’s domestic subsidiaries) |
| Issue price and disposal price | ¥21,380 per share |
| Total issue value | ¥180,318,920 |
| Amount of funds to be raised | Total payment amount: ¥180,318,920; estimated net proceeds: Not disclosed |
| Payment date | 15 May 2026 |
| Intended allottee | Name Directors of the Company, excluding outside directors / Number of Employees 5 / Number of Shares 5,246 shares, Name Corporate officers of the Company / Number of Employees 9 / Number of Shares 1,446 shares, Name Directors and corporate officers of the Company’s domestic subsidiaries / Number of Employees 13 / Number of Shares 1,742 shares |
| Intended allottee's holding policy | During the restriction period, the shares may not be transferred, pledged or otherwise disposed of. For the covered corporate officers and others, the policy is to promote long-term, stable share ownership. |
| Total number of issued shares | The total number of issued shares will not increase because this is a disposal of treasury shares. |
| Basis for determining the amount to be paid | The closing price of the Company’s common shares on the Tokyo Stock Exchange market on 16 April 2026 was ¥21,380. No discount or premium rate was stated. |
| Transfer restriction period | Covered directors: from 15 May 2026 to 15 May 2029. Covered corporate officers and others: from 15 May 2026 until the date on which they cease to hold any of the positions specified according to their respective status. |
| Conditions for lifting transfer restrictions | Covered directors must continuously hold the prescribed position from the date of the immediately preceding annual general meeting of shareholders as of 15 May 2026 through the date of the following annual general meeting of shareholders. Covered corporate officers and others must continuously hold the prescribed position during the service period corresponding to their respective status. If they lose the position due to death or another reason deemed justifiable by the Board of Directors, some or all of the restrictions will be lifted in proportion to the period of service. In the event of a reorganization or similar transaction, all restrictions will be lifted immediately before the business day preceding the effective date. |
| Reason for acquisition without consideration | Upon expiration of the restriction period or immediately after the loss of the prescribed position, the Company will automatically acquire without consideration any shares for which the restrictions have not been lifted. |
| Categories and Number of Persons Covered | 5 directors of the Company, excluding outside directors, 5,246 shares; 9 corporate officers (executive officers) of the Company, 1,446 shares; and 13 directors and corporate officers (executive officers) of the Company's domestic subsidiaries, 1,742 shares |
| Total Stock-Based Compensation | Covered directors: total monetary compensation receivables of ¥112,159,480. Covered corporate officers and others: total monetary receivables of ¥68,159,440. The compensation framework separate from the existing monetary compensation framework is limited to ¥200 million per year (the amount recognized as an accounting expense). |
Items this document does not state (13)
Estimated issuance expensesSpecific use of fundsDilution RateExercise priceExercise periodNumber of Stock Acquisition RightsUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide incentives for the sustained enhancement of corporate value and promote the sharing of value with shareholders. For the covered corporate officers and others, the purpose is also to promote long-term, stable share ownership.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.